Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers
NCT05380882
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancers
Interventions
DRUG:
TQB2930 injection
Sponsor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.